Correlates of Clinical Restenosis Following Intracoronary Implantation of Drug-Eluting Stents

American Journal of Cardiology

Volumn 100, Issue 6, 2007, Pages 965-969

  Roy, Probal ^a   Okabe, Teruo ^a   Pinto Slottow, Tina L ^a   Steinberg, Daniel H ^a   Smith, Kimberly ^a   Torguson, Rebecca ^a   Xue, Zhenyi ^a   Gevorkian, Natalie ^a   Satler, Lowell F ^a   Kent, Kenneth M ^a   Suddath, William O ^a   Pichard, Augusto D ^a   Waksman, Ron ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ARTICLE; BYPASS SURGERY; CARDIOVASCULAR RISK; COHORT ANALYSIS; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; HUMAN; IMPLANTATION; IN-STENT RESTENOSIS; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PRIORITY JOURNAL; REVASCULARIZATION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PACLITAXEL; RETREATMENT; SIROLIMUS; STENTS; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 34548432105     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2007.04.036     Document Type: Article

References (27)

1. Al Suwaidi J., Berger P.B., and Holmes Jr. D.R. Coronary artery stents. JAMA 284 (2000) 1828-1836
2. Kastrati A., Schomig A., Elezi S., Schuhlen H., Dirschinger J., Hadamitzky M., Wehinger A., Hausleiter J., Walter H., and Neumann F.J. Predictive factors of restenosis after coronary stent placement. J Am Coll Cardiol 30 (1997) 1428-1436
3. Cutlip D.E., Chauhan M.S., Baim D.S., Ho K.K., Popma J.J., Carrozza J.P., Cohen D.J., and Kuntz R.E. Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials. J Am Coll Cardiol 40 (2002) 2082-2089
4. Marx S.O., and Marks A.R. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation 104 (2001) 852-855
5. Rowinsky E.K., and Donehower R.C. Paclitaxel (taxol). N Engl J Med 332 (1995) 1004-1014
6. Morice M.C., Serruys P.W., Sousa J.E., Fajadet J., Ban Hayashi E., Perin M., Colombo A., Schuler G., Barragan P., Guagliumi G., Molnar F., Falitico R., and RAVEL Study Group. Randomized study with the sirolimus-coated Bx Velocity balloon-expandable stent in the treatment of patients with de novo native coronary artery lesions. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346 (2002) 1773-1780
7. Moses J.W., Leon M.B., Popma J.J., Fitzgerald P.J., Holmes D.R., O'Shaughnessy C., Caupto R.P., Kereiakes D.J., Williams D.O., Teirstein P.S., Jaeger J.L., Kuntz R.E., and SIRIUS Investigators. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 349 (2003) 1315-1323
8. Stone G.W., Ellis S.G., Cox D.A., Hermiller J., O'Shaughnessy C., Mann J.T., Turco M., Caupto R., Bergin P., Greenberg P., Popmar J.J., Russell M.E., and TAXUS-IV Investigators. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350 (2004) 221-231
9. Camenzind E., Steg P.G., and Wijns W. Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern. Circulation 115 (2007) 1440-1445
10. Pfisterer M., Brunner-La Rocca H., Buser P., Rickenbacher P., Hunziker P., Mueller C., Jeger R., Bader F., Osswald S., Kaiser C., and BASKET-LATE Investigators. Late clinical events after clopidogrel discontinuation may limit the benefit of drug-eluting stents; an observational study of drug-eluting versus bare-metal stents. J Am Coll Cardiol 48 (2006) 2584-2591
11. Kastrati A., Dibra A., Mehilli J., Mayer S., Pinieck S., Pache J., Dirschinger J., and Schomig A. Predictive factors of restenosis after coronary implantation of sirolimus- or paclitaxel-eluting stents. Circulation 113 (2006) 2293-2300
12. Lee C.W., Park D.W., Lee B.K., Kim Y.H., Hong M.K., Kim J.J., Park S.W., and Park S.J. Predictors of restenosis after placement of drug-eluting stents in one or more coronary arteries. Am J Cardiol 97 (2006) 506-511
13. Berenguer A., Mainar V., Bordes P., Valencia J., Gomez S., and Lozano T. Incidence and predictors of restenosis after sirolimus-eluting stent implantation in high-risk patients. Am Heart J 150 (2005) 536-542
14. Lemos P.A., Hoye A., Goedhart D., Arampatzis C.A., Saia F., van der Giessen W.J., McFadden E., Sianos G., Smits P.C., Hofma S.H., et al. Clinical, angiographic, and procedural predictors of angiographic restenosis after sirolimus-eluting stent implantation in complex patients: an evaluation from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) study. Circulation 109 (2004) 1366-1370
15. Ong A.T., Serruys P.W., Aoki J., Hoye A., van Mieghem C.A., Rodriguez-Granillo G.A., Valgimigli M., Sonnenschein K., Regar E., van der Ent M., et al. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry. J Am Coll Cardiol 45 (2005) 1135-1141
16. Kim Y.H., Park S.W., Lee C.W., Hong M.K., Gwon H.C., Jang Y., Lee M.M., Koo B.K., Oh D.J., Seung K.B., et al. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions. Catheter Cardiovasc Interv 67 (2006) 181-187
17. Tsagalou E., Chieffo A., Iakovou I., Ge L., Sangiorgi G.M., Corvaja N., Airoldi F., Montorfano M., Michev I., and Colombo A. Multiple overlapping drug-eluting stents to treat diffuse disease of the left descending coronary artery. J Am Coll Cardiol 45 (2005) 1570-1573
18. Aoki J., Ong A.T., Rodriguez Granillo G.A., McFadden E.P., van Mieghem C.A., Valgimigli M., Tsuchida K., Sianos G., Regar E., de Jaegere P.P., et al. "Full metal jacket" (stented length > or = 64 mm) using drug-eluting stents for de novo coronary artery lesions. Am Heart J 150 (2005) 994-999
19. Sakurai R., Ako J., Morino Y., Sonoda S., Kaneda H., Terashima M., Hassan A.H., Leon M.B., Moses J.W., Popma J.J., et al., SIRIUS Trial Investigators. Predictors of edge stenosis following sirolimus-eluting stent deployment (a quantitative intravascular ultrasound analysis from the SIRIUS trial). Am J Cardiol 96 (2005) 1251-1253
20. Park D.W., Park S.W., Park K.H., Lee B.K., Kim Y.H., Lee C.W., Hong M.K., Kim J.J., and Park S.J. Frequency of and risk factors for stent thrombosis after drug-eluting stent implantation during long-term follow-up. Am J Cardiol 98 (2006) 352-356
21. Kereiakes D.J., Wang H., Popma J.J., Kuntz R.E., Donohoe D.J., Schofer J., Schampaert E., Meier B., Leon M.B., and Moses J.W. Periprocedural and late consequences of overlapping Cypher sirolimus-eluting stents: pooled analysis of five clinical trials. J Am Coll Cardiol 48 (2006) 21-31
22. Fitzgerald P.J., Oshima A., Hayase M., Metz J.A., Bailey S.R., Baim D.S., Cleman M.W., Deutsch E., Diver D.J., Leon M.B., et al. Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation 102 (2000) 523-530
23. Omerawsingh P.V., Mintz G.S., Schalij M.J., Zwinderman A.H., Jukema J.W., van der Wall E.E., and Tulip Study. Thrombocyte activity evaluation and effects of Ultrasound guidance in Long Intracoronary stent Placement: intravascular ultrasound guidance improves angiographic and clinical outcome of stent implantation for long coronary artery stenoses: final results of a randomized comparison with angiographic guidance (TULIP Study). Circulation 107 (2003) 62-67
24. Fujii K., Mintz G.S., Kobayashi Y., Carlier S.G., Takebayashi H., Yasuda T., Moussa I., Dangas G., Mehran R., Lansky A.J., et al. Contribution of stent underexpansion to recurrence after sirolimus-eluting stent implantation for restenosis. Circulation 109 (2004) 1085-1088
25. Ako J., Morino Y., Terashima M., Honda Y., Sonoda S., Leon M.B., Moses J.W., Yock P.G., and The SIRIUS Investigators. Optimal geometry is still important with sirolimus eluting stents: incomplete stent expansion as a risk for target lesion revascularization. J Am Coll Cardiol 43 suppl A (2004) 84A
26. Schofer J., and Schluter M. Coronary restenosis after implantation of drug-eluting stents. Minerva Cardioangiol 53 (2005) 43-48
27. Iakovou I., Stankovic G., Orlic D., Vitrella G., Sangiorgi G., Corvaja N., Chieffo A., Michev I., Airoldi F., Spanos V., and Colombo A. Overdilation of Cypher 3.0mm 6 cells stent: clinical consequence. J Am Coll Cardiol 43 suppl A (2004) 45A